Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial

Faster, Cleaner, Better.

Igene Biotechnology Inc (IGNE)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] by (Cboe BZX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]

Balance Sheet for [[ item.sessionDateDisplayLong ]]

Fiscal Year End Date: 12/31

(Values in U.S. thousands)

	12-1990	12-1989	12-1988	12-1987	12-1986
Assets
Current Assets
Cash & Cash Equivalents	N/A	305	1,893	14	26
Marketable Securities	10	0	0	5,640	2,353
Receivables	20	20	147	5	60
Inventories	30	78	346	27	2
Other current assets	-10	84	93	151	97
TOTAL	$50	$486	$2,478	$5,837	$2,537

Non-Current Assets
PPE Net	N/A	128	375	521	608
Investments And Advances	0	0	8	0	21
Other Non-Current Assets	4	4	4	10	31
TOTAL	$4	$132	$386	$531	$660

Total Assets	$140	$618	$2,864	$6,368	$3,197

Liabilities
Current Liabilities
Accounts payable and accrued liabilities	0	124	222	192	339
Accrued Expenses	6	7	21	0	0
Other current liabilities	N/A	30	30	100	0
TOTAL	$200	$160	$273	$292	$339

Non-Current Liabilities
Long Term Debt	1,500	1,500	1,500	0	0
TOTAL	$1,500	$1,500	$1,500	$N/A	$N/A

Total Liabilities	$1,700	$1,660	$1,773	$292	$339

Shareholders' Equity
Common Shares	70	25	25	18	18
Retained earnings	-16,880	-15,861	-13,743	-10,639	-7,967
Other shareholders' equity	10	619	607	6,106	-13
TOTAL	$-2,080	$-1,042	$1,091	$6,076	$2,859

Total Liabilities And Equity	$-380	$618	$2,864	$6,368	$3,197